Searches , social queries for IXEKIZUMAB
Search references for IXEKIZUMAB. Phrases containing IXEKIZUMAB
See searches and references containing IXEKIZUMAB!
Search references for IXEKIZUMAB. Phrases containing IXEKIZUMAB
See searches and references containing IXEKIZUMAB!IXEKIZUMAB
Medication used to treat autoimmune diseases
Ixekizumab, sold under the brand name Taltz, is an injectable medication for the treatment of autoimmune diseases. Chemically, it is a form of a humanized
Ixekizumab
American pharmaceutical company
(Trulicity) for the treatment of type 2 diabetes (7% of 2025 revenues); ixekizumab (Taltz) for the treatment of autoimmune diseases (6% of 2025 revenues);
Eli_Lilly_and_Company
Heterodimeric cytokine acting as mediator of inflammation
conditions. Guselkumab is another monoclonal antibody against IL-23. Ixekizumab, an IL-17A antagonist, has been reported to have faster onset of action
Interleukin_23
Autoimmune diseases of the skin
to inhibit TNF-α signaling. Additional monoclonal antibodies, such as ixekizumab, have been developed against pro-inflammatory cytokines and inhibit the
Psoriasis
Type of arthritis of the spine
IL-17, an important part of the inflammatory system: secukinumab and ixekizumab. They are often considered in cases where TNFi drugs are not effective
Ankylosing_spondylitis
Drug made from biological source
ulcerative colitis, Crohn's disease monoclonal antibody α4β7 integrin blocker ixekizumab Taltz plaque psoriasis, psoriatic arthritis, ankylosing spondylitis, non-radiographic
Biopharmaceutical
Group of proteins
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_17
Mammalian protein found in Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_23_subunit_alpha
Drug used to treat allergic diseases
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Dupilumab
Human monoclonal antibody medication
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Sarilumab
Mammalian protein found in Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_1_beta
Marker on immune cells
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
CD4
Receptors on the surface of cells
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Type_I_cytokine_receptor
Monoclonal antibody
Ustekinumab Humanized Anrukinzumab Bimekizumab Clazakizumab Gevokizumab Ixekizumab Mirikizumab† Lebrikizumab Olokizumab† Perakizumab Risankizumab Spesolimab
Spartalizumab
Monoclonal antibody
This mechanism is similar to that of another anti-psoriasis antibody, ixekizumab, which however binds to IL-17 itself. Brodalumab was developed by Amgen
Brodalumab
Monoclonal antibody
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Guselkumab
Monoclonal antibody
Ustekinumab Humanized Anrukinzumab Bimekizumab Clazakizumab Gevokizumab Ixekizumab Mirikizumab† Lebrikizumab Olokizumab† Perakizumab Risankizumab Spesolimab
Theralizumab
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
IL13RA2
advanced solid tumors Itolizumab Alzumab mab humanized CD6 Y psoriasis Ixekizumab Taltz mab humanized IL-17A Y autoimmune diseases Izenivetmab Lenivia mab
List of therapeutic monoclonal antibodies
List_of_therapeutic_monoclonal_antibodies
Cytokine receptor which binds interleukin 1
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin-1_receptor
Member of the interleukin 1 receptor family
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
ST2_cardiac_biomarker
Chemical compound
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Clazakizumab
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin 10 receptor, beta subunit
Interleukin_10_receptor,_beta_subunit
American professor of dermatology
Burge, Russel; Cameron, Gregory (August 2018). "Efficacy and safety of ixekizumab over 4 years of open-label treatment in a phase 2 study in chronic plaque
Mark_G._Lebwohl
Adverse reaction that occurs initially at the site of an injection or infusion
Agada, N; Mallbris, L (1 February 2018). "Safety and Tolerability of Ixekizumab: Integrated Analysis of Injection-Site Reactions from 11 Clinical Trials"
Injection_site_reaction
Pharmaceutical drug
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Anakinra
Protein-coding gene in the species Homo sapiens
trials which found that two anti-IL-17A antibodies, namely secukinumab and ixekizumab significantly benefit these patients. However, IL-17A inhibitors show
Interleukin-17A
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
IL1RL2
Pharmaceutical drug classification
Briakinumab L04AC10 Secukinumab L04AC11 Siltuximab L04AC12 Brodalumab L04AC13 Ixekizumab L04AC14 Sarilumab L04AC15 Sirukumab L04AC16 Guselkumab L04AC17 Tildrakizumab
ATC_code_L04
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
IL1RAP
Monoclonal antibody
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Pacibekitug
Monoclonal antibody against IL-17
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Secukinumab
Biopharmaceutical drug
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Ustekinumab
Cytokine protein
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_6
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
EBI3
Mammalian cytokine
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_40
U.S. nonprofit organization
teriflunomide, alemtuzumab, and daclizumab for multiple sclerosis; and ixekizumab and brodalumab for psoriasis or psoriatic arthritis. ICER's governing
Institute for Clinical and Economic Review
Institute_for_Clinical_and_Economic_Review
Interleukin
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_12
Type of protein receptor
targeting IL-17 receptor is approved for the treatment of psoriasis. Ixekizumab and secukinumab approved for plaque psoriasis are antibodies which target
Interleukin-17_receptor
Form of immunotherapy
Aventis 3/2/2020 intravenous chimeric CD38 multiple myeloma 761113 Link ixekizumab Taltz Eli Lilly 3/22/2016 subcutaneous humanized IL-17A plaque psoriasis
Monoclonal_antibody_therapy
Pharmaceutical drug
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Canakinumab
Mammalian protein found in humans
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_8
Monoclonal antibody
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Lebrikizumab
Pharmaceutical drug
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Basiliximab
Drugs to suppress IL-6 signalling
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Anti-interleukin-6
Monoclonal antibody medication
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Mepolizumab
Group of cytokines
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin
Group of cytokine proteins
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin-1_family
Drug class
arthritis. Examples: Anakinra Tocilizumab Canakinumab Secukinumab Ustekinumab Ixekizumab Sarilumab Selective costimulation modulator of T cells is a type of biologic
Antiarthritics
Immunosuppressive drug
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Tocilizumab
Lymphocyte receptor specific for Interleukin-2
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
IL-2_receptor
Mammalian protein found in Mus musculus
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_4
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_1-alpha
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
IL31RA
Cytokine with structural similarity to Interleukin-2
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_15
Immunoglobulin superfamily
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin-1_receptor_family
Overview of and topical guide to immunology
Guselkumab Lebrikizumab Risankizumab Tildrakizumab Ustekinumab IL-17A Ixekizumab Secukinumab Cellular target CD3 Muromonab-CD3 Otelixizumab Teplizumab
Outline_of_immunology
Monoclonal antibody
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Inolimomab
Mammalian protein found in humans
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_2
Pharmaceutical drug
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Reslizumab
Pharmaceutical drug
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Siltuximab
Drugs that modify immune system response
include adalimumab, certolizumab, etanercept, golimumab, infliximab, ixekizumab, belimumab, and ustekinumab. Extracts from some medicinal mushrooms are
Biological_response_modifier
Pharmaceutical drug
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Oprelvekin
Protein that in humans is encoded by the IL33 gene
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_33
Monoclonal antibody
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Benralizumab
Monoclonal antibody
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Tralokinumab
Group of anti-viral cytokines
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interferon_type_III
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_29
Anti-inflammatory cytokine
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_10
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin 15 receptor, alpha subunit
Interleukin_15_receptor,_alpha_subunit
Monoclonal antibody
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Sirukumab
Monoclonal antibody
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Tildrakizumab
Pharmaceutical drug
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Daclizumab
Protein and coding gene in humans
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin-1 receptor antagonist
Interleukin-1_receptor_antagonist
Mammalian protein found in humans
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_21
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin 36 receptor antagonist
Interleukin_36_receptor_antagonist
Protein in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_31
Mammalian protein found in humans
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
CSF2RB
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin-4_receptor
Protein complex
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin-15_receptor
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
IL18BP
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
IL12A
Growth factor secreted by stromal cells in the bone marrow and thymus
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_7
Transmembrane proteins
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Type_II_cytokine_receptor
Type of cytokine
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_5
Mammalian protein found in Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin-3_receptor
Protein found in humans
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_19
Medication used to treat arthritis
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Perakizumab
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_16
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin-9_receptor
Protein found in humans
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interferon_lambda_receptor_1
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_11
Protein found in humans
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Alpha-taxilin
Cell surface receptor for interleukin-10
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin-10_receptor
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin_3
Protein found in humans
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin-23_receptor
Protein found on the surface of cells
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin-7_receptor
Protein-coding gene in humans
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Common_gamma_chain
Mammalian protein found in Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
IL2RA
Protein-coding gene in the species Homo sapiens
Interleukin 17 (A, B, C, D, E (interleukin 25), F) Antibodies: Brodalumab Ixekizumab Perakizumab Remtolumab Secukinumab Vunakizumab IL-18 Agonists: Iboctadekin
Interleukin-12_subunit_beta
travel, tourism, insurance
IXEKIZUMAB
IXEKIZUMAB
IXEKIZUMAB
IXEKIZUMAB
IXEKIZUMAB
IXEKIZUMAB
IXEKIZUMAB
IXEKIZUMAB
IXEKIZUMAB
travel, tourism, insurance